Omada Health (OMDA)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Omada Health (OMDA) trades at $16.48 with AI Score 61/100 (Grade B+). Omada Health is a virtual-care provider focused on chronic condition management. Market cap: 980M, Sector: Healthcare.
Last analyzed: May 7, 2026OMDA stock analysis for 2026: Analysts have set a consensus price target of $23.50 for Omada Health, suggesting 42.6% upside from the current price of $16.48. The AI MoonshotScore is 61/100, indicating a bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
OMDA: 2/4 perspectives are bullish. Dominant signal: Moon AI bullish.
Omada Health (OMDA) Healthcare & Pipeline Overview
Omada Health delivers virtual care programs for chronic conditions, distinguishing itself through clinically validated, digitally delivered interventions. Addressing cardiometabolic disease, musculoskeletal issues, and behavioral health, Omada operates in the expanding healthcare information services sector, leveraging technology to improve patient outcomes and access to care.
What Is the Investment Thesis for OMDA?
Omada Health presents a compelling investment thesis centered on its position in the expanding virtual-care market and its focus on chronic condition management. With a gross margin of 65.5%, Omada demonstrates a strong ability to generate profit from its services. Key value drivers include the increasing adoption of virtual care, the rising prevalence of chronic diseases, and Omada's ability to deliver clinically validated programs that improve patient outcomes and reduce healthcare costs. The company's partnerships with employers and health plans provide a stable revenue stream and opportunities for further expansion. The beta of 1.33 suggests higher volatility compared to the market. Growth catalysts include expanding into new therapeutic areas, increasing market penetration, and forming strategic partnerships. Potential risks include competition from other virtual-care providers, regulatory changes, and the need to continuously demonstrate the effectiveness of its programs.
Based on FMP financials and quantitative analysis
OMDA Key Highlights
- Market Cap of $0.79B reflects Omada Health's valuation in the virtual care market.
- Gross Margin of 65.5% indicates strong profitability in delivering virtual care services.
- Profit Margin of -4.9% suggests the company is still investing in growth and expansion.
- Beta of 1.33 indicates higher volatility compared to the market, potentially due to its growth stage.
- Focus on chronic conditions aligns with the increasing prevalence of these diseases and the growing demand for virtual care solutions.
Who Are OMDA's Competitors?
Who Are OMDA's Competitors?
OMDA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| TDOC Teladoc Health, Inc. | $7.05 | -3.56% | 2B | 49 |
| AMWL American Well Corporation (AMWL) | $7.80 | -1.39% | 131M | 52 |
| HNGE Hinge Health, Inc. | $54.50 | +1.15% | 5B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.00 | +0.00% | $20.00M | 67 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| FOXO FOXO Technologies Inc. | $0.00 | +0.00% | 3K | 63 |
| BRGX BioRegenx, Inc. | $0.01 | +0.00% | $8.06M | 61 |
| CMPD CompuMed, Inc. | $6.75 | +0.00% | $8.71M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OMDA's Key Strengths?
- Clinically validated programs
- Established partnerships with employers and health plans
- Data-driven insights and personalized approach
- Comprehensive virtual-care platform
What Are OMDA's Weaknesses?
- Profit Margin is negative
- Reliance on partnerships for revenue
- Competition from established healthcare providers and digital health companies
- Limited brand recognition compared to larger players
What Could Drive OMDA Stock Higher?
- Expansion into new therapeutic areas, such as women's health or dermatology, to broaden the company's addressable market.
- Increased adoption of virtual care by employers and health plans, driven by the need to reduce healthcare costs and improve access to care.
- New clinical data demonstrating the effectiveness of Omada's programs in improving patient outcomes and reducing healthcare costs (expected Q4 2026).
- Strategic partnerships with other healthcare providers and technology companies to expand Omada's capabilities and market reach.
What Are the Key Risks for OMDA?
- Increased competition from other virtual-care providers, including established healthcare companies and emerging digital health startups.
- Regulatory changes and healthcare policy that could impact the reimbursement of virtual-care services.
- Data security and privacy breaches that could damage Omada's reputation and lead to legal liabilities.
- The need to continuously demonstrate the effectiveness of Omada's programs in improving patient outcomes and reducing healthcare costs.
What Are the Growth Opportunities for OMDA?
- Expansion into New Therapeutic Areas: Omada Health has the opportunity to expand its virtual-care programs into new therapeutic areas beyond its current focus on cardiometabolic disease, musculoskeletal care, and behavioral health. This could include areas such as dermatology, women's health, or oncology. The market for virtual specialty care is estimated to reach $75 billion by 2030, presenting a significant growth opportunity for Omada. By leveraging its existing platform and expertise, Omada can efficiently launch new programs and attract new customers.
- Increased Market Penetration: Omada Health can increase its market penetration by expanding its partnerships with employers, health plans, and health systems. The company can target new customer segments, such as small and medium-sized businesses, or expand its reach within existing customer accounts. The market for virtual chronic condition management is estimated to reach $40 billion by 2027, providing ample opportunity for Omada to grow its customer base and revenue.
- Strategic Partnerships and Acquisitions: Omada Health can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This could include partnering with other digital health companies, acquiring complementary technologies, or expanding into new geographic markets. Strategic partnerships can provide access to new customers, technologies, and expertise, while acquisitions can accelerate growth and expand Omada's product offerings.
- International Expansion: Omada Health has the opportunity to expand its virtual-care programs into international markets. The demand for virtual care is growing globally, driven by factors such as increasing healthcare costs, aging populations, and the growing adoption of technology. By adapting its programs to meet the needs of different markets, Omada can tap into new sources of revenue and growth. The global virtual care market is expected to reach $55 billion by 2027.
- Data-Driven Personalization: Omada Health can further leverage its data and analytics capabilities to personalize its programs and improve patient outcomes. By analyzing patient data, Omada can identify individual needs and preferences and tailor its programs accordingly. This can lead to improved engagement, adherence, and ultimately, better health outcomes. The market for personalized medicine is estimated to reach $3.5 billion by 2025, highlighting the growing importance of data-driven personalization in healthcare.
What Opportunities Does OMDA Have?
- Expansion into new therapeutic areas
- Increased market penetration through new partnerships
- International expansion
- Strategic acquisitions and partnerships
What Threats Does OMDA Face?
- Regulatory changes and healthcare policy
- Competition from other virtual-care providers
- Data security and privacy concerns
- Need to continuously demonstrate program effectiveness
What Are OMDA's Competitive Advantages?
- Clinically Validated Programs: Omada's programs are backed by clinical evidence, demonstrating their effectiveness in improving patient outcomes.
- Established Partnerships: Omada has established partnerships with major employers, health plans, and health systems, providing a stable revenue stream and a competitive advantage.
- Data-Driven Insights: Omada leverages data and analytics to personalize its programs and improve patient engagement and outcomes.
- Integrated Platform: Omada's platform integrates personalized coaching, connected devices, and data-driven insights, providing a comprehensive virtual-care solution.
What Does OMDA Do?
Omada Health, founded with the mission to transform healthcare through technology, is a virtual-care provider based in the United States. The company focuses on delivering clinically validated programs for individuals managing chronic conditions. These programs, offered digitally between traditional doctor visits, address critical areas such as cardiometabolic disease (including diabetes and heart health), musculoskeletal care, and behavioral health. Omada's approach integrates personalized coaching, connected devices, and data-driven insights to empower individuals to make sustainable lifestyle changes and improve their health outcomes. Since its inception, Omada Health has evolved from a diabetes-focused program to a comprehensive virtual-care platform addressing multiple chronic conditions. This expansion reflects the growing recognition of the interconnectedness of various health challenges and the need for integrated, holistic care. Omada partners with employers, health plans, and health systems to provide its programs to their members and patients. By leveraging technology, Omada aims to improve access to high-quality care, reduce healthcare costs, and enhance the overall patient experience. The company's commitment to clinical rigor and data-driven results has positioned it as a leader in the rapidly growing virtual-care market.
What Products and Services Does OMDA Offer?
- Provides virtual care programs for chronic conditions.
- Offers clinically validated programs for cardiometabolic disease.
- Delivers digital interventions for musculoskeletal care.
- Provides behavioral health support through virtual platforms.
- Partners with employers, health plans, and health systems.
- Uses personalized coaching and connected devices to improve patient outcomes.
- Employs data-driven insights to empower individuals to make sustainable lifestyle changes.
How Does OMDA Make Money?
- Generates revenue through contracts with employers, health plans, and health systems.
- Charges fees for its virtual-care programs based on enrollment and engagement.
- Offers subscription-based access to its platform and services.
What Industry Does OMDA Operate In?
Omada Health operates within the rapidly expanding healthcare information services industry, driven by the increasing adoption of virtual care and the growing prevalence of chronic diseases. The market is characterized by intense competition, with numerous players offering digital health solutions. Omada differentiates itself through its focus on clinically validated programs and its partnerships with employers and health plans. The industry is expected to continue to grow rapidly, fueled by technological advancements, increasing healthcare costs, and the growing demand for convenient and accessible care. Omada is well-positioned to capitalize on these trends, but faces challenges from established healthcare providers and emerging digital health companies.
Who Are OMDA's Key Customers?
- Employers seeking to improve the health and productivity of their employees.
- Health plans looking to reduce healthcare costs and improve member outcomes.
- Health systems aiming to expand access to care and improve patient satisfaction.
OMDA Financials
OMDA Latest News
-
How This Eli Lilly-Tied IPO Stock Fared In Its First Quarter
Yahoo! Finance: OMDA News · May 8, 2026
-
Omada Health Q1 Earnings Call Highlights
marketbeat.com · May 8, 2026
-
Barclays Maintains Overweight on Omada Health, Raises Price Target to $20
benzinga · May 8, 2026
-
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $21
benzinga · May 8, 2026
OMDA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OMDA.
Price Targets
Consensus target: $23.50
OMDA MoonshotScore
What does this score mean?
The MoonshotScore rates OMDA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Who Are OMDA's Competitors?
Latest News
How This Eli Lilly-Tied IPO Stock Fared In Its First Quarter
Omada Health Q1 Earnings Call Highlights
Barclays Maintains Overweight on Omada Health, Raises Price Target to $20
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $21
Leadership: Sean Duffy
CEO
Sean Duffy is the CEO of Omada Health, leading the company's efforts to transform healthcare through virtual-care programs. He has a background in healthcare and technology, with experience in building and scaling innovative healthcare solutions. Prior to joining Omada Health, Sean held leadership positions at various healthcare companies, where he focused on improving patient outcomes and reducing healthcare costs. He brings a wealth of knowledge and expertise to Omada Health, driving the company's growth and innovation.
Track Record: Under Sean Duffy's leadership, Omada Health has expanded its virtual-care programs to address a wider range of chronic conditions and has established partnerships with major employers, health plans, and health systems. He has overseen the company's growth in market share and revenue, while maintaining a focus on clinical rigor and data-driven results. Sean has also led Omada Health through successful funding rounds, securing capital to fuel its continued expansion.
Omada Health Healthcare Stock: Key Questions Answered
What does Omada Health do?
Omada Health is a virtual-care provider that offers clinically validated programs for chronic conditions such as cardiometabolic disease, musculoskeletal care, and behavioral health. The company partners with employers, health plans, and health systems to provide its programs to their members and patients. Omada's programs combine personalized coaching, connected devices, and data-driven insights to empower individuals to make sustainable lifestyle changes and improve their health outcomes. By leveraging technology, Omada aims to improve access to high-quality care, reduce healthcare costs, and enhance the overall patient experience, positioning itself as a leader in the evolving healthcare landscape.
What do analysts say about OMDA stock?
As a private company, there is no publicly traded stock for Omada Health (OMDA). Therefore, there are no analyst ratings or price targets available. However, the company's performance and potential can be evaluated based on its market position, growth prospects, and financial metrics. Omada Health operates in the rapidly growing virtual-care market and has established partnerships with major employers and health plans. Its focus on clinically validated programs and data-driven insights positions it well for continued growth. Investors interested in the virtual-care market may find Omada Health to be an attractive investment opportunity, although due diligence is essential.
What are the main risks for OMDA?
Omada Health faces several risks, including increasing competition from other virtual-care providers, regulatory changes in the healthcare industry, and the need to continuously demonstrate the effectiveness of its programs. The virtual-care market is becoming increasingly crowded, with established healthcare companies and emerging digital health startups vying for market share. Regulatory changes, such as changes in reimbursement policies, could impact Omada's revenue and profitability. Additionally, Omada must continuously demonstrate the clinical and economic value of its programs to maintain its partnerships and attract new customers. Failure to address these risks could negatively impact Omada's growth and financial performance.
What are the key factors to evaluate for OMDA?
Omada Health (OMDA) currently holds an AI score of 61/100, indicating moderate score. Analysts target $23.50 (+43% from $16.48). Key strength: Clinically validated programs. Primary risk to monitor: Increased competition from other virtual-care providers, including established healthcare companies and emerging digital health startups. This is not financial advice.
How frequently does OMDA data refresh on this page?
OMDA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven OMDA's recent stock price performance?
Recent price movement in Omada Health (OMDA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $23.50 implies 43% upside from here. Notable catalyst: Clinically validated programs. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider OMDA overvalued or undervalued right now?
Determining whether Omada Health (OMDA) is overvalued or undervalued requires examining multiple metrics. Analysts target $23.50 (+43% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying OMDA?
Before investing in Omada Health (OMDA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are based on estimates and may not reflect actual performance.